Refractory Liver Carcinoma
2 clinical trials · Condition
◉ Watch Refractory Liver Carcinoma
| Record | Firm | Date |
|---|---|---|
| IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer (NCT03655002) | City of Hope Medical Center | 2019-02-21 |
| Pembrolizumab (MK-3475) in Hepatocellular Carcinoma (NCT02940496) | M.D. Anderson Cancer Center | 2016-12-09 |
Track Refractory Liver Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.